The FDA is looking to get thrifty with its approved drugs. | The framework would leverage existing safety data on approved drugs to provide new options to patients with unmet medical needs, the FDA explained.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Amid multiple efforts to rein in steep drug costs in the U.S., Colorado has received the all-clear to take matters into its own…
Targeted protein degradation is changing how drug discovery teams think about disease biology. For many years, small molecule…
Modern drug development demands faster, more scalable gene expression insights. Download this white paper to explore how…
While dealmaking and investment dollars may be flowing across biopharma once again, acute challenges tied to policy, pricing and…
With questions already swirling about the actual affordability impact of t | With questions already swirling about the actual…
Amid efforts in Germany to retool the country’s drug spending, the U.S. | Amid efforts in Germany to retool the country’s drug…
